Hemostasis and fibrinolysis in COVID-19 survivors 6 months after intensive care unit discharge.

Anne-Marije HulshofDionne C W BraekenChahinda Ghossein-DohaSusanne van SantenJan-Willem E M Sels Gerhardus J A J M Kuiper Iwan C C van der Horst Hugo Ten Cate Bas C T van Bussel Renske H OlieYvonne M C Henskens

Published in: Research and practice in thrombosis and haemostasis (2021)

Six months after COVID-19 ICU discharge, no persisting hypercoagulable or hypofibrinolytic profile was detected by tPA ROTEM. Nevertheless, increased D-dimer and fibrinogen concentrations persist up to 6 months in some patients, warranting further exploration of the role of hemostasis in long-term morbidity after hospital discharge.

Keyphrases

intensive care unit
coronavirus disease
sars cov
end stage renal disease
ejection fraction
newly diagnosed
mechanical ventilation
chronic kidney disease
peritoneal dialysis
patient reported outcomes
acute respiratory distress syndrome
patient reported
extracorporeal membrane oxygenation